Rivaroxaban for the treatment of superficial vein thrombosis, experience at King's College Hospital

被引：4
|
作者：
Clapham, Rachel E. [1 ]
Speed, Victoria [1 ,2 ]
Czuprynska, Julia [1 ]
Gazes, Anna [1 ]
Guppy, Simon [1 ]
Patel, Raj K. [1 ]
Rea, Catherine [1 ]
Vadher, Bipin [1 ]
Arya, Roopen [1 ]
Roberts, Lara N. [1 ]
机构：
[1] Kings Coll Hosp NHS Fdn Trust, Kings Thrombosis Ctr, Dept Haematol Med, London, England
[2] Kings Coll London, Inst Phar maceut Sci, London, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2022年 / 196卷 / 01期
关键词：
rivaroxaban; superficial vein thrombosis; anticoagulants; factor Xa inhibitor; DIAGNOSIS;
D O I：
10.1111/bjh.17757
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E3 / E6
页数：4
相关论文
共 50 条
  • [1] More on normal prothrombin times in the presence of therapeutic levels of rivaroxaban - early experience from King's College Hospital
    Patel, Jignesh P.
    Roberts, Lara N.
    Chitongo, Paradzai B.
    Patel, Raj K.
    Arya, Roopen
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (05) : 717 - 718
  • [2] Diagnosis and treatment of superficial vein thrombosis
    Bauersachs, R. M.
    HAMOSTASEOLOGIE, 2013, 33 (03): : 232 - 240
  • [3] Treatment of Superficial Vein Thrombosis: A Systematic Review and Meta-Analysis
    Duffett, Lisa
    Kearon, Clive
    Rodger, Marc
    Carrier, Marc
    THROMBOSIS AND HAEMOSTASIS, 2019, 119 (03) : 479 - 489
  • [4] Rivaroxaban in the treatment of upper extremity deep vein thrombosis: A single-center experience and review of the literature
    Schastlivtsev, Ilya
    Lobastov, Kirill
    Tsaplin, Sergey
    Kanzafarova, Irina
    Barinov, Victor
    Laberko, Leonid
    Rodoman, Grigory
    Zhuravlev, Sergey
    THROMBOSIS RESEARCH, 2019, 181 : 24 - 28
  • [5] Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review
    Wichers, Iris M.
    Di Nisio, Marcello
    Buller, Harry R.
    Middeldorp, Saskia
    HAEMATOLOGICA, 2005, 90 (05) : 672 - 677
  • [6] Superficial vein thrombosis treated for 45 days with rivaroxaban versus fondaparinux: rationale and design of the SURPRISE trial
    Werth, Sebastian
    Bauersachs, Rupert
    Gerlach, Horst
    Rabe, Eberhard
    Schellong, Sebastian
    Beyer-Westendorf, Jan
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2016, 42 (02) : 197 - 204
  • [7] Superficial vein thrombosis treated for 45 days with rivaroxaban versus fondaparinux: rationale and design of the SURPRISE trial
    Sebastian Werth
    Rupert Bauersachs
    Horst Gerlach
    Eberhard Rabe
    Sebastian Schellong
    Jan Beyer-Westendorf
    Journal of Thrombosis and Thrombolysis, 2016, 42 : 197 - 204
  • [8] Successful treatment with rivaroxaban of an extended superficial vein thrombosis in a patient with acquired antithrombin deficiency due to Peg-asparaginase treatment
    Mark Plander
    Tamás Szendrei
    Imre Bodó
    János L. Iványi
    Annals of Hematology, 2015, 94 : 1257 - 1258
  • [9] Successful Treatment of Partial Portal Vein Thrombosis (PVT) with Low Dose Rivaroxaban
    Lenz, K.
    Dieplinger, B.
    Buder, R.
    Piringer, P.
    Rauch, M.
    Voglmayr, M.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (10): : 1175 - 1177
  • [10] Treatment of upper extremity deep vein thrombosis with apixaban and rivaroxaban
    Houghton, Damon E.
    Casanegra, Ana I.
    Peterson, Lisa G.
    Cochuyt, Jordan
    Hodge, David O.
    Vlazny, Danielle
    McBane, Robert D.
    Froehling, David
    Wysokinski, Waldemar E.
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (07) : 817 - 823
12345